Rhabdomyosarcoma (RMS) is a type of soft tissue cancer that most commonly affects children and adolescents. It’s often found in skeletal...
What is Rhabdomyosarcoma?
read more
Research
What is Ewing Sarcoma?
Ewing Sarcoma Defined Ewing sarcoma is a cancerous bone tumor that affects children, adolescent and young adults—usually developing during...
What Is Osteosarcoma?
Osteosarcoma is the most common type of bone cancer in children and adolescents. The tumor often originates in the long bones of the body,...
Rally Announces $1M in Awards to Consortium Grants
We are thrilled to share that Rally Foundation for Childhood Cancer Research has awarded a total of $1 million in funding for Consortium...
Rally Foundation Announces More Than $1M for Independent Investigator Grants
Rally is thrilled to announce that $1,250,000 has been awarded through this year’s Independent Investigator Grants, supporting innovative...
$600,000 for Rally-Funded Young Investigator Grants
We’re delighted to announce the $600,000 awarded for this year’s Young Investigator Grants, which support the next generation of childhood...
Rally Announces $850,000 for Postdoctoral and Clinical Research Fellow Grants
Rally is thrilled to announce $850,000 awarded to our 2026 Postdoctoral and Clinical Research Fellow Grants! At Rally, we know the future...
Rally Is Proud to Award $150,000 to Three Outside the Box Grants
Breakthroughs happen with outside-the-box thinking, in science, in medicine and especially in childhood cancer research. At Rally...
Rally Is Excited to Announce $1.4M in Funding for Career Development Awards
At Rally, we believe that innovative research begins with innovative researchers. That’s why we are thrilled to announce the recipients of...
Rally Foundation Awards $1M in Grants to Celebrate 20 Years of Advancing Research and Driving Discoveries
In 2026, Rally Foundation for Childhood Cancer Research is thrilled to award $1 million in 20/20 Alumni Visionary Grants to 10 researchers...
Rally Foundation Awards a Record $7M in Grants to 94 Childhood Cancer Researchers
In 2026, Rally Foundation for Childhood Cancer Research is thrilled to award a total of $7 million in childhood cancer research grants to...
What Is Rally’s 20/20: Alumni Visionary Grant?
Honoring 20 years of innovative ideas and the visionaries behind them. For 20 years, Rally Foundation for Childhood Cancer Research has...
What is Charity Navigator?
When you are in the market for a new refrigerator, you ask your neighbors and friends for recommendations, and maybe even consult Consumer...
What Is an Outside the Box Grant?
What Is an Outside the Box Grant? Outside the box thinking is critical for progress in any field. For childhood cancer, outside the box...
What Is a Rally Career Development Award?
Career development awards are important. But why? Investigators in their first independent faculty appointment are at a critical career...
Research
What is Rhabdomyosarcoma?
Rhabdomyosarcoma (RMS) is a type of soft tissue cancer that most commonly affects children and adolescents. It’s often found in skeletal muscle tissue or organs, such as the head and neck area, the urinary system, the reproductive system or appendages like the arms and legs. Rhabdomyosarcoma is part of a larger grouping of cancers called sarcomas which emerge in the body’s connective tissues, like muscles, fat, bones, blood vessels and joints. There are 50 different types of sarcomas. There...
What is Ewing Sarcoma?
Ewing Sarcoma Defined Ewing sarcoma is a cancerous bone tumor that affects children, adolescent and young adults—usually developing during puberty between the ages of 10 and 20 years old. Approximately 87% of Ewing sarcomas are in the long bone, meaning the arm, thigh, shin and pelvis. On rare occasion, Ewing sarcomas can occur in soft tissue like cartilage or nerves. These are called pPNET tumors and can be found in the nerve tissue in many parts of the body; if a pPNET is found in the chest,...
What Is Osteosarcoma?
Osteosarcoma is the most common type of bone cancer in children and adolescents. The tumor often originates in the long bones of the body, and while osteosarcoma frequently starts in a particular bone, it can potentially move to other sites in the body, such as the lungs and other bones. This movement, known as metastasis, makes the disease more difficult to treat. “For patients that present with no evidence of metastatic or disseminated disease, the overall prognosis is about 70-75%,” said...
Rally Announces $1M in Awards to Consortium Grants
We are thrilled to share that Rally Foundation for Childhood Cancer Research has awarded a total of $1 million in funding for Consortium Grants this year. So, what exactly is a consortium? In short, it’s teamwork at its best! A consortium brings together three or more institutions, such as hospitals and universities, to work together on a grant-supported research project. A principal investigator from the lead institution submits an application for the grant with the support of at least two...
Rally Foundation Announces More Than $1M for Independent Investigator Grants
Rally is thrilled to announce that $1,250,000 has been awarded through this year’s Independent Investigator Grants, supporting innovative research in the fight against childhood cancer! But who exactly are these independent investigators? Independent investigators are generally professors or faculty members who lead their own labs and drive forward big-picture ideas. As the principal investigators, they’re the ones developing ideas, designing the studies, mentoring young scientists and...
$600,000 for Rally-Funded Young Investigator Grants
We’re delighted to announce the $600,000 awarded for this year’s Young Investigator Grants, which support the next generation of childhood cancer researchers! But who exactly are these young investigators? In short, they’re bright, passionate scientists and doctors working tirelessly to find better treatments and, ultimately, cures for childhood cancer. Young investigators are typically within five years of completing their fellowship. At this crucial stage in their careers, they’re focused on...